Business
PPJ Enterprise Triples Its Stock Price and Volume After Signing Agreement With Hemp, Inc.'s IHMMCC to Segue Into the Medical Marijuana Sector
PPJ Enterprise Triples Its Stock Price and Volume After Signing Agreement With Hemp, Inc.'s IHMMCC to Segue Into the Medical Marijuana Sector.
About this update from Ppj Healthcare Enterprises, Inc.
[{"type":"text","content":"\nLAS VEGAS, June 23, 2014 (GLOBE NEWSWIRE) -- Hemp, Inc.'s (OTC:HEMP) wholly owned subsidiary, The Industrial Hemp and Medical Marijuana Consulting Company, Inc. (IHMMCC), announced today that it has signed a consultant agreement with PPJ Enterprise (OTC:PPJE), a leader in medical practice information management. The strategic alliance with PPJ Enterprise has already proven advantageous for PPJE and its shareholders, as PPJE's stock rose 150% and 30% respectively just after news of the alliance was released late last week by PPJE.\n\n\tAccording to Hemp, Inc. CEO, Bruce Perlowin, IHMMCC will lend its industry expertise in the form of professional consulting services and valuable contacts and resources in order for PPJE to successfully segue into the medical marijuana industry. While PPJE is a known leader in proprietary automated healthcare reimbursement cycle software and online health information digital-systems software, the company has now added a division to perform Medical Marijuana potency tests through an affiliate blood lab that can test for the principal psychoactive constituent of the cannabis plant, THC, as well as THCA, and other medicinal cannabinoids such as CBD, CBG, CBN, CBDA, and beta-Caryophyllene.\n\n\tAccording to Chandana Basu, CEO of PPJ Enterprise, PPJE's exigency for public partner ventures and effective industry guidance in the medical marijuana and industrial hemp industry lead it to IHMMCC. \"We are looking forward to what our partnership with Hemp, Inc.'s IHMMCC will bring, especially with the increased demand for more accurate drug testing.\" said Basu.  While the most popular drug test is the urine test, urine tests can not detect the psychoactive component in marijuana, THC, thus \"blood tests are a better detector of recent use, since they measure the active presence of THC in the system,\" according to California NORML.\n\n\tPerlowin, CEO of Hemp, Inc. (OTC:HEMP) said, \"PPJE, we feel, will make a huge impact in the Medical Marijuana sector. They are not only leaders in their field but are bringing the much needed service, of testing, to our industry. Testing the potency of medicinal cannabinoids can aid in research and development of more effective treatments.\"\n\n\tCardiothoracic and Vascular Surgeon, David B. Allen, M.D., says \"Cannabis is Medicine\". In a recent a...